Quality of life of Uthiravatha suronitham(Rheumatoid arthritis)

Completed

• Conditions: Stiffness of joint, not elsewhereclassified,

• Registration Number: CTRI/2022/01/039808
• Lead Sponsor: National Institute of Siddha

Brief Summary

Rheumatoid arthritis is the most commonpersistent inflammatory arthritis. The symptoms are pain, joint swelling andstiffness affecting the small joints of the hand, feet, and wrists. Large jointinvolvement, systemic symptoms and extra articular features may also occur. **OBJECTIVE:** To estimate the quality of life (QOL) inUthiravatha suronitham patients reporting at OPD of Ayothidoss Panditharhospital, NIS through Rheumatoid Arthritis Flare Questionnaire (RA-FQ) and toassess the predisposing factors of Uthiravatha suronitham with respect age,gender, chronicity of illness, personal history, occupational history, familyhistory, stress etc. **MATERIALS ANDMETHODS:** This is a Hospital based crosssectional study, included 100  Uthiravatha suronitham patients reported OPDof ayothidoss pandithar hospital were enrolled  based on inclusion  and exclusion criteria. After obtaininginformed consent form, data were collected by using  Rheumatoid Arthritis Flare Questionnaire(RA-FQ) and Beck’s Depression Inventory form to estimate the quality of life. **RESULTS :** In 100 Uthiravatha suronithampatients, over all  score is 42.9 in  RA-FQ (Maximum 50) questionnaire. In beck’sdepression Inventory showed that  38%patients had Moderate depression and 33% patients had Severe depression. **CONCLUSION:** Rheumatoid arthritissignificantly affects the quality of life of patients both physically andmentally.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-02
• Study Completion: 2022-04-20
• Last Update Posted: 2022-05-29

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Age 30 TO 65 Years Male Female and Transgender K/C/O Uthiravatha suronitham(Rheumatoid Arthritis)patients with sero negative sero positive RA Lab investigations patients who are willing to give informed consent.

Exclusion Criteria

Age below 30 and above 65 years Patients with normal CRP Anti CCP test results Patient who are not willing to give consent form Patients defects (Osteoarthritis Psoriatic arthritis Gout arthritis).

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The outcome of this study will provide validate measure of quality of life and provide a tool for improving the evaluation of siddha medications for Uthiravatha Suronitham	6months

Trial Locations

Locations (1)

AYOTHIDOSS PANDITHAR HOSPITAL; 🇮🇳 Kancheepuram, TAMIL NADU, India

AYOTHIDOSS PANDITHAR HOSPITAL

🇮🇳Kancheepuram, TAMIL NADU, India

Dr A Surya

Principal investigator

8072897366

suryaasaithambi1995@gmail.com